(S (NP (NP (NNS Advances)) (PP (PP (IN in) (NP (NN healthcare))) (CC and) (PP (IN in) (NP (NP (DT the) (NN quality)) (PP (IN of) (NP (NN life))))))) (VP (ADVP (RB significantly)) (VB increase) (NP (JJ human) (NN life) (NN expectancy))) (. .))
(S (PP (IN With) (NP (NP (DT the) (NN ageing)) (PP (IN of) (NP (NNS populations))))) (, ,) (NP (JJ new) (JJ un-faced) (NNS challenges)) (VP (VBP are) (VP (VBN brought) (PP (TO to) (NP (NN science))))) (. .))
(S (NP (DT The) (JJ human) (NN body)) (VP (VBZ is) (VP (ADVP (RB naturally)) (VBN selected) (S (VP (TO to) (VP (VB be) (ADJP (JJ well-functioning)) (PP (IN until) (NP (NP (DT the) (NN age)) (PP (IN of) (NP (NN reproduction)))))))) (S (VP (TO to) (VP (VB keep) (S (NP (DT the) (NNS species)) (ADJP (VBP alive)))))))) (. .))
(S (ADVP (RB However)) (, ,) (SBAR (IN as) (S (NP (DT the) (NN lifespan)) (VP (VBZ extends)))) (, ,) (NP (NP (JJ unseen) (NNS problems)) (ADJP (JJ due) (PP (TO to) (NP (DT the) (NN body) (NN deterioration))))) (VP (NN emerge)) (. .))
(S (S (NP (EX There)) (VP (VBP are) (NP (NP (JJ several) (JJ age-related) (NNS diseases)) (PP (IN with) (NP (DT no) (JJ appropriate) (NN treatment)))))) (: ;) (S (ADVP (RB therefore)) (, ,) (NP (DT the) (JJ complex) (VBG ageing) (NN phenomena)) (VP (VBZ needs) (NP (JJ further) (NN understanding)))) (. .))
(S (NP (NP (NN Immunosenescence)) (, ,) (NP (NP (DT the) (NN ageing)) (PP (IN of) (NP (DT the) (NN immune) (NN system)))) (, ,)) (VP (VBZ is) (ADJP (RB highly) (VBN correlated) (PP (TO to) (NP (NP (DT the) (JJ negative) (NNS effects)) (PP (IN of) (NP (VBG ageing))) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (DT the) (NN increase)) (PP (IN of) (NP (JJ auto-inflammatory) (NNS diseases)))) (CC and) (NP (NP (NN decrease)) (PP (IN in) (NP (NP (NN responsiveness)) (PP (TO to) (NP (JJ new) (NNS diseases)))))))))))) (. .))
(S (PP (IN Besides) (NP (ADJP (JJ clinical) (CC and) (JJ mathematical)) (NNS tools))) (, ,) (NP (PRP we)) (VP (VBP believe) (SBAR (S (NP (EX there)) (VP (VBZ is) (NP (NN opportunity) (S (VP (TO to) (ADVP (JJ further)) (VP (JJ exploit) (NP (NN simulation) (NNS tools)) (S (VP (TO to) (VP (VB understand) (NP (NN immunosenescence))))))))))))) (. .))
(S (PP (VBN Compared) (PP (TO to) (NP (JJ real-world) (NN experimentation)))) (, ,) (NP (NNS benefits)) (VP (VBP include) (NP (NN time) (CC and) (NN cost) (NN effectiveness)) (PP (JJ due) (TO to) (NP (NP (NP (DT the) (JJ laborious) (, ,) (NN resource-intensiveness)) (PP (IN of) (NP (DT the) (JJ biological) (NN environment)))) (CC and) (NP (NP (DT the) (NN possibility)) (PP (IN of) (S (VP (VBG conducting) (NP (NNS experiments)) (PP (IN without) (NP (JJ ethic) (NNS restrictions)))))))))) (. .))
(S (S (VP (VBN Contrasted) (PP (IN with) (NP (JJ mathematical) (NNS models))))) (, ,) (NP (NN simulation) (NN modelling)) (VP (VBZ is) (ADJP (RBR more) (JJ suitable) (PP (IN for) (S (VP (VBG representing) (NP (NP (JJ complex) (NNS systems)) (CC and) (NP (NN emergence)))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (DT the) (NN belief) (SBAR (DT that) (S (NP (NN simulation) (NNS models)) (VP (VBP are) (ADJP (JJR easier) (SBAR (S (VP (TO to) (VP (VB communicate) (PP (IN in) (NP (JJ interdisciplinary) (NN contexts))))))))))))) (. .))
(S (NP (PRP$ Our) (NN work)) (VP (VBZ investigates) (NP (NP (DT the) (NN usefulness)) (PP (IN of) (NP (NNS simulations))) (S (VP (TO to) (VP (VB understand) (NP (NN immunosenescence)))))) (PP (IN by) (S (VP (VBG employing) (NP (NP (CD two) (JJ different) (NN simulation) (NNS methods)) (, ,) (NP (RRC (JJ agent-based) (CC and)) (NP (NN system) (NNS dynamics) (NN simulation)))) (, ,) (PP (TO to) (NP (NP (DT a) (NN case) (NN study)) (PP (IN of) (NP (NP (JJ immune) (NNS cells) (NN depletion)) (PP (IN with) (NP (NN age))))))))))) (. .))
